• 한국의학물리학회지:의학물리
• /
• 제12권2호
• /
• pp.141-146
• /
• 2001

치료효과를 보증하기 위해서는 조사선량의 5% 이내의 선량오차가 방사선생물학적 의미가 높은 것으로 잘 알려져 있다. 따라서 종양치료를 위한 강내조사 선원이나 선형가속기의 고선량율의 선량 평가는 정확하고 안정적 평가가 이루어져야 된다. 선량을 평가 교정하기 위해 전리함의 교정 인정기관의 교정상수를 유지하기 위해 선진국에서는 기하학적으로 고정된 표준선원과 전리함의 사용을 오래 전부터 권고해 왔다. 본 연구는 전리함의 감도 변화를 측정할 수 있는 Sr-90 시험선원을 이용한 임의의 기준 전리함의장기간 안정성이 1.00$\pm$0.01 의 오차 범위에 있음을 알 수 있었고, 고선량률 원격강내조사선원인 Co-60 선원에 대한 기준전리함의 출력선량에 대한 임상측정용 전리함의 출력선량은 평균 0.997 $\pm$ 0.01의 오차범위에서 평가될 수 있었으며, 최대오차는 예상선량에 -2.5% 였다. 이 실험을 통해 반감기가 긴 시험선원을 이용하여 임상 측정용 공기전리함의 안정적 성능을 유지할 수 있음을 알 수 있다.

• 한국자기학회지
• /
• 제20권2호
• /
• pp.45-51
• /
• 2010

비파괴검사는 탐지물체에 물리적 손상을 가하지 않고 내부 정보를 파악할 수 있어 다양한 분야에서 이용되고 있다. 그 중 전자기를 이용한 물체의 형상추정방법의 경우 역 유한요소법을 이용하여야 하지만 이는 비선형성이 강하고 수치계산이 복잡하고 측정 센서의 개수가 미지수의 개수보다 훨씬 적어 정확한 결과를 얻는데 어려움이 있다. 본 논문에서는 탐지물체에 의한 자기장 변화 신호만을 이용하여, 물체의 시스템 내 각 센서별 위치에서 물체와 등가면적의 원의 비교를 통해 비교적 간편하게 자성물체의 부피를 판정하고 형상추정을 위한 다양한 보정과정을 거쳐 탐지물체의 형상판정이 가능한 알고리즘을 제안하고 검증하였다.

• 약학회지
• /
• 제60권2호
• /
• pp.64-72
• /
• 2016

Jakyakgamcho-tang is a well-known traditional herbal medicine and has been used for the treatment of mainly pains in oriental medicine. In this study, analytical method for the quantitative determination of the eleven marker components, gallic acid (1), oxypaeoniflorin (2), paeoniflorin (3), albiflorin (4), liquiritin (5), isoliquiritin (6), ononin (7), liquiritigenin (8), benzoylpaeoniflorin (9), paeonol (10), and glycyrrhizin (11) in Jakyakgamcho-tang decoction was performed using an ultra-performance liquid chromatography-electrospray ionization-mass spectrometer. The analytical column for separation of the compounds 1~11 was used an UPLC BEH $C_{18}$ ($100{\times}2.1mm$, $1.7{\mu}m$) column and column oven temperature was maintained at $45^{\circ}C$. The mobile phase consisted of 0.1% (v/v) aqueous formic acid (A) and acetonitrile (B) by gradient elution. The flow rate was 0.3 ml/min and injection volume was $2.0{\mu}l$. Correlation coefficient in the calibration curves of the compounds 1~11 were showed a good linearity with more than 0.99. The limit of detection and limit of quantification values of the compounds 1~13 were detected in the ranges 0.06~18.43 ng/ml and 0.18~58.29 ng/ml, respectively. Among the compounds 1~11, the compounds 10 were not detected in this sample, while the ten compounds, 1~9 and 11, were detected $44.05{\sim}19,289.05{\mu}g/g$ in Jakyakgamcho-tang extract.

• 한국농공학회논문집
• /
• 제55권6호
• /
• pp.19-30
• /
• 2013

This study is to evaluate the use of dual-polarization radar data for storm runoff modeling in Namgang dam (2,293 $km^2$) watershed using KIMSTORM (Grid-based KIneMatic wave STOrm Runoff Model). The Bisl dual-polarization radar data for 3 typhoons (Khanun, Bolaven, Sanba) and 1 heavy rain event in 2012 were obtained from Han River Flood Control Office. Even the radar data were overall less than the ground data in areal average, the spatio-temporal pattern between the two data was good showing the coefficient of determination ($R^2$) and bias with 0.97 and 0.84 respectively. For the case of heavy rain, the radar data caught the rain passing through the ground stations. The KIMSTORM was set to $500{\times}500$ m resolution and a total of 21,372 cells (156 rows${\times}$137 columns) for the watershed. Using 28 ground rainfall data, the model was calibrated using discharge data at 5 stations with $R^2$, Nash and Sutcliffe Model Efficiency (ME) and Volume Conservation Index (VCI) with 0.85, 0.78 and 1.09 respectively. The calibration results by radar rainfall showed $R^2$, ME and VCI were 0.85, 0.79, and 1.04 respectively. The VCI by radar data was enhanced by 5 %.

• 대한화학회지
• /
• 제44권6호
• /
• pp.556-562
• /
• 2000

간접 요오드화법의 UV 검출을 이용한 흐름주입분석에 의한 아염소산 이온의 정량에 관하여 연구하였다. 산성 조건하에서 아염소산은 요오드화 이온을 요오드로 산화시키고 자신은 염화 이온으로 환원된다. UV 370nm에서 노란 색으로 발색된 요오드의 흡광도를 측정하여 아염소산 이온을 간접적으로 정량 하였다. 흐름주입분석-UV검출 장치를 이용한 무기성 소독부산물인 아염소산 이온을 선택적으로 정량하기 위한 분석 인자로서 혼합 및 반응코일 길이, 산성 용리액의 pH, 요오드화 이온의 농도, 주입고리부피, 반응 온도, 유속을 최적화 하였다. 조제수로부터 산화제나 방해 물질들을 제거하기 위한 가리움제를 조사하였다. 아염소산 이온에 대한 0.002~0.2 mg/L의 선형 농도 범위에서 검정곡선은 0.999이상의 상관계수를 나타내였다. 아염소산 이온의 검출한계는 0.18 ${\mu}g/L$이었다.

• 사상체질의학회지
• /
• 제25권1호
• /
• pp.51-61
• /
• 2013

Objectives We performed the simultaneous analysis for three compounds in Cheongsimyeonja-tang (CSYJT) and evaluated its anti-obesity effect. Methods The column for separation of three compounds was used Gemini $C_{18}$ column and maintained at $40^{\circ}C$. The mobile phase for gradient elution consisted of two solvent systems. The analysis was carried out at a flow rate of 1.0 mL/min with PDA detection at 275 nm. The injection volume was $10{\mu}L$. 3T3-L1 preadipocytes were differentiated into adipocytes by adding insulin, dexamethasone and 3-isobutyl-1-methylxanthine (IBMX) for 8 days in the absence or presence of CSYJT. Anti-obesity effects of CSYJT were evaluated by Oil Red O staining, glycerol-3-phosphate dehydrogenase (GPDH) activity, triglyceride contents, and leptin production. Results Calibration curves were acquired with $r^2$ >0.9999. The contents of baicalin, wogonoside and baicalein in CSYJT were 14.54-14.65 mg/g, 5.24-5.27 mg/g and 0.01-0.02 mg/g, respectively. CSYJT showed inhibitory effect on lipid accumulation and GPDH activity in the differentiated 3T3-L1 cells. Furthermore, CSYJT significantly decreased contents of triglyceride and leptin production in 3T3-L1 adipocytes. Conclusions These results will be helpful to improve quality control and anti-obesity effect of Taeeumin CSYJT.

• Archives of Pharmacal Research
• /
• 제27권2호
• /
• pp.259-264
• /
• 2004

The purpose of the present study was to investigate the pharmacokinetics of PEG-hemoglobin SB 1, a modified bovine hemoglobin with polyethylene glycol, after its single and multiple administration in beagle dogs. For this purpose, the analytical method of free hemoglobin in the plasma was developed and validated. Excellent linearity ($r^2$=0.999) was observed in the calibration curve data, with the limit of quantification of 0.005 g/dL. The precision and the deviation of the theoretical values for accuracy were always within $\pm$15％ in both the between-and the within-day results. The method was tested by measuring the plasma concentrations following intravenous administration to beagle dogs and was shown to be suitable for pharmacokinetic studies. In a single dose study, the plasma half-life (t$_{1}$2/) increased and the total body clearance (Cl$_{t}$) decreased with the dose (i.e., 0.017 to 0.75 gHb/kg as PEG-hemoglobin SB1) in both sexes. The volume of distribution at steady-state (Vd$_{ss}$ ) showed no difference with the dose. In contrast, the values of t$_{1}$2/, CL$_{t}$ and the area under the plasma concentration-time curve (AUC) after the multiple dose were significantly different from those of the single dose administration. The values of t$_{1}$2/ in the multiple administration were about two times higher-than that of the single dose. As a result, t$_{1}$2/ of hemoglobin after the administration of PEG-hemoglobin SB1 was about 15-30 h, indicating the PEG modification of the hemoglobin lead to a prolongation of plasma concentration of the protein. Therefore, these observations suggested that the PEG modification of hemoglobin is potentially applicable in the hemoglobin-based therapeutics.tics.

• 대한화학회지
• /
• 제55권1호
• /
• pp.46-49
• /
• 2011

감도가 높고 선택적인 추출-분광광도법은 미량의 시메티딘의 측정을 위해 개발되어 왔다. 이 방법은 클로로포름안에 브로모티몰 블루(BTB)와 함께 이온 쌍으로 시메티딘의 추출에 기초했다. 그리고 417 nm에서 흡광도를 측정하고 있다. pH, BTB의 농도, 클로로포름의 부피, 섞는 시간과 같은 다른 변수들의 효과를 연구하였다. 또한, 추출에서 간섭이온의 효과도 연구하였다. 보정곡선은 0.9997의 상관계수와 함께 0.25~8 ug/mL의 범위에서 선형이다. 3Sb에 기초한 검출한계는 0.14 ug/mL이고 시메티딘의 0.1과 4.0 ug/mL의 10번 측정에 대한 상대표준편차는 3.2와 1.49%이었다. 제안된 방법은 좋은 회수와 함께 약제 샘플에서 시메티딘의 측정에 적용되었다.

• Natural Product Sciences
• /
• 제22권2호
• /
• pp.93-101
• /
• 2016

For efficient quality control of the Samryeongbaekchul-san decoction, a powerful and accurate an ultra-performance liquid chromatography (UPLC) coupled with electrospray ionization (ESI) tandem mass spectrometry (MS) method was developed for quantitative analysis of the thirteen constituents: allantoin (1), spinosin (2), liquiritin (3), ginsenoside Rg1 (4), liquiritigenin (5), platycodin D2 (6), platycodin D (7), ginsenoside Rb1 (8), glycyrrhizin (9), 6-gingerol (10), atractylenolide III (11), atractylenolide II (12), and atractylenolide I (13). Separation of the compounds 1 - 13 was performed on a UPLC BEH $C_{18}$ column ($2.1{\times}100mm$, $1.7{\mu}m$) at a column temperature of $40^{\circ}C$ with a gradient solvent system of 0.1% (v/v) formic acid aqueous-acetonitrile. The flow rate and injection volume were 0.3 mL/min and $2.0{\mu}L$. Calibration curves of all compounds were showed good linearity with values of the correlation coefficient ${\geq}0.9920$ within the test ranges. The values of limits of detection and quantification for all analytes were 0.04 - 4.53 ng/mL and 0.13 - 13.60 ng/mL. The result of an experiment, compounds 2, 6, 12, and 13 were not detected while compounds 1, 3 - 5, and 7 - 11 were detected with 1,570.42, 5,239.85, 299.35, 318.88, 562.27, 340.87, 12,253.69, 73.80, and $115.01{\mu}g/g$, respectively.

• 분석과학
• /
• 제34권5호
• /
• pp.193-201
• /
• 2021

We have demonstrated a sensitive analytical method of measuring oleracone D in mouse plasma using a liquid chromatography-tandem mass spectrometry (LC-MS/MS). Oleracone D and oleracone F (internal standard) in mouse plasma samples were processed using a liquid-liquid extraction method with methyl tertbutyl ether, resulting in high and reproducible extraction recovery (80.19-82.49 %). No interfering peaks around the peak elution time of oleracone D and oleracone F were observed. The standard calibration curves for oleracone D ranged from 0.5 to 100 ng/mL and were linear with r² of 0.992. The inter- and intra-day accuracy and precision and the stability fell within the acceptance criteria. The pharmacokinetics of oleracone D following intravenous and oral administration of oleracone D at doses of 5 mg/kg and 30 mg/kg, respectively, were investigated. When oleracone D was intravenously injected, it had first-order elimination kinetics with high clearance and volume of distribution values. The absolute oral bioavailability of this compound was calculated as 0.95 %, with multi-exponential kinetics. The low aqueous solubility and a high oral dose of oleracone D may explain the different elimination kinetics of oleracone D between intravenous and oral administration. Collectively, this newly developed sensitive LC-MS/MS method of oleracone D could be successfully utilized for investigating the pharmacokinetic properties of this compound and could be used in future studies for the lead optimization and biopharmaceutic investigation of oleracone D.